Results 1 to 10 of about 5,420,950 (275)

Major Thalassemia, Screening or Treatment: An Economic Evaluation Study in Iran [PDF]

open access: yesInternational Journal of Health Policy and Management, 2022
BackgroundBeta-thalassemia minor and thalassemia major are an autosomal recessive disease with hypochromic, microcytic anemia, and morbidities, Today, therapeutic advances have significantly improved the life expectancy of thalassemia major patients, but
Firooz Esmaeilzadeh   +4 more
doaj   +2 more sources

Endocrine Function in Thalassemia Major [PDF]

open access: bronzeThe Journal of Clinical Endocrinology & Metabolism, 1968
Abstract Seven patients with thalassemia major, ranging in age from 6½ to 23 yr, were studied. Growth retardation was present in all except the youngest patient. Thyroid and adrenal function was normal. Three patients, however, showed an unexplained increase in the serum protein bound iodine level.
Braden Kuo   +2 more
openalex   +3 more sources

Hypogonadism in thalassemia major patients

open access: yesJournal of Clinical & Translational Endocrinology, 2016
Despite recent advances in iron chelation therapy, excess iron deposition in pituitary gonadotropic cells remains one of the major problems in thalassemic patients.
Sasima Srisukh   +2 more
doaj   +4 more sources

Changes in coagulation status in patients with β-thalassemia in Iraq: A case-control study

open access: yesMedical Journal of Babylon, 2022
Background: The pathogenesis β-thalassemia is characterized by anemia resulting from reduced β-globin synthesis with low hemoglobin A (HbA) production and higher production of hemoglobin A2 (HbA2) and fetal hemoglobin (HbF).
Hussein Abdalzehra Wadaha   +2 more
doaj   +1 more source

Evaluation of the Association of Transferrin Receptor Type 2 Gene Mutation (Y250X) with Iron Overload in Major β-Thalassemia [PDF]

open access: yesArchives of Razi Institute, 2021
Thalassemia is an inherited blood disorder in which the body produces defective hemoglobin. One of the important processes to reduce the complication of major β-thalassemia is blood transfusion that leads to elevated ferritin levels in the blood.
J Abdulmalek Jaafar, N. A. M Al-Rashedi
doaj   +1 more source

Evaluation of Factors influencing the birth of Thalassemia in Family Members with Thalassemia Major in Southeast Iran in 2021 [PDF]

open access: yesJournal of Advanced Biomedical Sciences, 2023
Background & Objectives: Beta-thalassemia is one of the complex diseases that causes many social and economic problems for the patient and his family. This study aimed to investigate factors influencing the birth of thalassemia (intermedia or major) in ...
Majid Naderi   +5 more
doaj  

A Hematologic Disease in the Turkish Republic of Northern Cyprus: Thalassemia Major

open access: yesMediterranean Nursing and Midwifery, 2023
Thalassemia is an inherited hematologic disease in which the body makes an abnormal form of hemoglobin. Patients are diagnosed with thalassemia major due to severe anemia and clinical symptoms.
Hazel Şahin Tarım, Fatma Öz
doaj   +1 more source

Determination of mutations in iron regulating genes of beta thalassemia major patients of Khyber Pakhtunkhwa, Pakistan

open access: yesMolecular Genetics & Genomic Medicine, 2020
Background Hepcidin and hemochromatosis (HFE) are iron regulatory proteins that are encoded by HAMP and HFE genes. Mutation in either HAMP gene or HFE gene causes Hepcidin protein deficiency that can lead to iron overload in beta thalassemia patients ...
Maryam Shah   +7 more
doaj   +1 more source

Psychopathology in thalassemia major

open access: yesPediatrics International, 2009
AbstractBackground:  Thalassemia major (TM) is a chronic disease with adverse emotional effects on both the child and the family. The aim of this study was to investigate the psychiatric state and behavioral problems of children with TM.Methods:  Twenty children diagnosed with TM and 34 healthy children were enrolled in this study carried out by the ...
Polat, A.   +4 more
openaire   +6 more sources

Clinical Course of COVID-19 in a Thalassemia Major Patient who Underwent Haematopoietic Stem Cell Transplantation

open access: yesBezmiâlem Science, 2021
We herein reported the course of Coronavirus diasease-19 (COVID-19) in a 21-year-old patient with thalassemia majo rdisease. The patient who underwent haematopoietic stem cell transplantation in 2013 and developed alloimmunization, presented with high ...
Aziz Ahmad HAMİDİ   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy